Нервно-мышечные болезни (Jan 2019)
European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience
- A. T. van der Ploeg,
- M. Ую Kruijshaar,
- A. Toscano,
- P. Laforet,
- C. Angelini,
- R. H. Lachmann,
- S. I. Pascual Pascual,
- M. Roberts,
- K. Rosler,
- T. Stulnig,
- P. A. van Doorn,
- P.Y. K. Van den Bergh,
- J. Vissing,
- B. Schoser
Affiliations
- A. T. van der Ploeg
- Center for Lysosomal and Metabolic Diseases, Erasmus MC University Medical Center
- M. Ую Kruijshaar
- Center for Lysosomal and Metabolic Diseases, Erasmus MC University Medical Center
- A. Toscano
- Department of Clinical and Experimental Medicine, University of Messina
- P. Laforet
- Paris-Est, Referral Center for Neuromuscular Disorders, Pitie-Salpetriere Hospital, Assistance Publique Hopitaux de Paris
- C. Angelini
- Angelini Fondazione S. Camillo Hospital, IRCCS
- R. H. Lachmann
- Charles Dent Metabolic Unit, National Hospital for Neurology and Neurosurgery
- S. I. Pascual Pascual
- Servicio de Neuropediatria, Hospital Universitario La Paz; Department of Paediatrics, Universidad Autonoma de Madrid
- M. Roberts
- Department of Neurology, Salford Royal NHS Foundation Trust
- K. Rosler
- Salford
- T. Stulnig
- Department of Medicine III, Medical University of Vienna
- P. A. van Doorn
- Department of Neurology, Erasmus MC University Medical Center
- P.Y. K. Van den Bergh
- Department of Neurology, Neuromuscular Reference Centre, University Hospitals St-Luc
- J. Vissing
- Copenhagen Neuromuscular Center, Rigshospitalet, University of Copenhagen
- B. Schoser
- Friedrich-Baur-Institute, Ludwig-Maximilians-University
- DOI
- https://doi.org/10.17650/2222-8721-2018-8-4-19-34
- Journal volume & issue
-
Vol. 8,
no. 4
pp. 19 – 34
